Patents by Inventor Mark Zamoyski

Mark Zamoyski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140163115
    Abstract: A novel pathogenesis underlying certain types of seizures and migraines is disclosed and the validated set of premises presented enable the deductive conclusion to be made that drugs that reduce the amount of calcium ions (Ca++) released from bone reduce seizure and migraine risk. The premises validated as true in the specifications include: 1) Known seizure and migraine triggers increase osteoclast mediated release of Ca++ from bone. 2) Increased Ca++ released from bone increases seizure and migraine risk by a) depolarization of nerve membranes, b) enhanced calcium channel mediated neurotransmitter release and increases muscle contractility by c) enhanced neurotransmitter release at the neuromuscular junction and d) enhanced removal of the tropomyosin block between actin and myosin. 3) Conversely, reducing Ca++ released from bone reduces seizure and migraine risk. 4) Cinacalcet reduces Ca++ released from bone. Therefore, cinacalcet reduces migraine risk.
    Type: Application
    Filed: December 12, 2012
    Publication date: June 12, 2014
    Inventors: Mark Zamoyski, Justin John Zamoyski
  • Publication number: 20090104206
    Abstract: Novel etiology and pathogenesis of premenstrual headache and premenstrual migraine are presented and novel treatment methods are provided. Present invention identifies how declining estrogen results in a transient elevation in extracellular calcium concentrations via osteoclast upregulation. The elevated extracellular calcium pathogenesis is then traced, from bone to brain, and includes depolarization of nerves, hyperactive neurotransmitter release, and hyperactive muscle contractility. Treatment methods are provided that target the earliest steps of the underlying etiology, in order to provide the most efficacious treatment possible. The treatment methods presented include use of compounds such as calcitonin and SERMs such as raloxifene.
    Type: Application
    Filed: October 19, 2007
    Publication date: April 23, 2009
    Inventors: Mark Zamoyski, Justin John Zamoyski
  • Patent number: 7507704
    Abstract: The present invention discloses that prior art protocols that administer HER receptor blockers concurrently with phase specific cytotoxic chemotherapeutics result in antagonistic function that prevents subsequent administrations of phase specific cytotoxic from functioning. The present invention provides protocols that allow the two classes of drugs to function synergistically. Moreover, the present invention also identifies that gompertzian tumor growth results in heterogeneity of cell cycle times in a tumor and that chemotherapeutic depopulation of the tumor results in accelerating cell cycle times, both of which preclude synchronicity of successive administrations of S-Phase cytotoxics relative to the progression of the S-Phase in the cancer cell population under prior art protocols. Present invention provides novel “synchronous” protocols for S-Phase cytotoxics, using HER blockers, to overcome this problem. Present invention also discloses how to integrate protocols of U.S. Pat. No.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: March 24, 2009
    Inventor: Mark Zamoyski
  • Patent number: 7309486
    Abstract: The present invention discloses protocols for HER cancers that are also endocrine dependent in a manner that provides dual action by using both HER antibodies and endocrine blockers/downregulators and insures function of S-Phase cytotoxics by administration of endocrines prior to administration of the S-Phase cytotoxic.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: December 18, 2007
    Inventor: Mark Zamoyski
  • Patent number: 7015244
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds by inhalation for chemical debridement of cells in the lungs of COPD patients are disclosed.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: March 21, 2006
    Inventor: Mark Zamoyski
  • Patent number: 7012091
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds by inhalation to inhibit inflammatory responses in the respiratory tract are disclosed.
    Type: Grant
    Filed: October 25, 2003
    Date of Patent: March 14, 2006
    Inventor: Mark Zamoyski
  • Publication number: 20040039047
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds by inhalation, to inhibit proliferation of, or reduce viability of, neoplasms in the lungs are disclosed. Methods for chemical debridement of diseased cells in the lungs of COPD patients as well as inhibition of inflammatory responses in the lungs are also disclosed.
    Type: Application
    Filed: August 13, 2001
    Publication date: February 26, 2004
    Inventor: Mark Zamoyski
  • Patent number: 6559178
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds to achieve apoptotic ablation of internal organs or internal non-malignant cell populations are disclosed.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: May 6, 2003
    Inventor: Mark Zamoyski
  • Patent number: 6486146
    Abstract: The invention discloses compositions and methods for increasing chemotherapeutic specificity to endocrine dependent cancers, and reducing systemic toxicity, through administration of endocrine hormones in conjunction with administration of phase specific chemotherapeutics. The invention also discloses why prior art phase specific chemotherapeutic regimens fail to achieve high cure rates for cancer. The failure relates to the Gompertzian acceleration, or reduction in cancer cell cycle time, induced by the chemotherapeutic reduction of tumor size, which in turn results in the cancer's lack of phase synchronicity to subsequent administrations of the phase specific chemotherapeutic(s).
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: November 26, 2002
    Inventor: Mark Zamoyski
  • Patent number: 6468247
    Abstract: A device for localized delivery of drugs into a user definable, three dimensional area within a tissue mass comprising a means for securely housing a plurality of hypodermic needles, a means of impaling and retracting the hypodermics into a tissue mass, and a means of injecting the contents of the hypodermics as they are being retracted.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: October 22, 2002
    Inventor: Mark Zamoyski
  • Patent number: 6355251
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds to chemexfoliate selected epidermal cell populations are disclosed.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: March 12, 2002
    Inventor: Mark Zamoyski
  • Patent number: 6346251
    Abstract: Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds to inhibit proliferation of psoriatic cell populations in the epidermis are disclosed.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: February 12, 2002
    Inventor: Mark Zamoyski
  • Patent number: 6342520
    Abstract: Sesquiterpenoid compounds and method for using such compounds to inhibit proliferation of malignant cells without inducing appreciable systemic cytotoxicity are disclosed. The compositions and methods presented also greatly reduce the duration of administration regimens compared to prior art and provide novel synergistic uses in combination with prior art chemotherapeutics.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: January 29, 2002
    Inventor: Mark Zamoyski
  • Patent number: 5952219
    Abstract: An apparatus for culturing and harvesting fungal spores and airborne particulates made up of a culture chamber with a means of issuing positive air pressure attached to one side and a harvesting chamber attached to the opposite side with means of dissipating the positive air pressure and means of collecting fungal spores and mycotoxins. Also a hydrophilic culture device made up of a plurality or horizontal and vertical planar members residing in a pan that can be inserted in the culture chamber.
    Type: Grant
    Filed: August 17, 1998
    Date of Patent: September 14, 1999
    Inventor: Mark Zamoyski
  • Patent number: 5778258
    Abstract: A photography booth including a plurality of vertical and horizontal frame elements attached to one another to form a generally cylindrical frame structure capable of detachably mounting a resilient sheet of material so as to form the resilient sheet of material into a cylindrical wall segment, capable of rotationally mounting a circular floor member within the cylindrical wall segment, having a camera mounting and positioning device, and having means for positioning a plurality of adjustable light sources.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: July 7, 1998
    Inventor: Mark Zamoyski
  • Patent number: 5267530
    Abstract: A framework residing in a cat litter box with sprockets, chains, and chain guides allowing a blade and basket mechanism to move horizontally through a cat litter box removing the cat excrement. The blade and basket are then elevated to a point at which they dump the cat excrement into an inclined chute. The cat excrement travels down the chute and into a disposable receptacle such as a plastic bag.
    Type: Grant
    Filed: December 28, 1992
    Date of Patent: December 7, 1993
    Inventor: Mark Zamoyski
  • Patent number: 5237708
    Abstract: A foot actuated toilet seat lifting, anti-slamming, and reseating device that functions exceptionally well over a wide range of user foot pressure variations or abruptness. The base member is substantially a lever pivotally attached to a fulcrum. The lever has a resilient material attached at the foot receiving end, an adjustable lifting rod pivotally attached at the opposite end, and a pneumatic device adjustably and pivotally attachable in between. Both the rod and pneumatic device extend upward and are pivotally attached to the toilet seat by a bracket. The pneumatic device does not provide resistance as the seat is lifted, dampens then stops the seat at the desired lift climax preventing slamming, and then provides a gentle return of the seat without slamming even if the users foot is abruptly removed. The resilient material on the foot receiving end feels good as well as aiding damping at lift climax, and aiding in return of the seat.
    Type: Grant
    Filed: December 3, 1992
    Date of Patent: August 24, 1993
    Inventor: Mark Zamoyski